Skip to content
Heart icon (animated) heart icon (static)
Share

Pharmaceutical Pipeline

  • Select programs in development, Phase 1 through Approval (removed after programs achieve approval in both US/EU)
  • Select Novel Therapy programs recently approved or with potential filings in the US/EU within a specified window as outlined in the Pharmaceutical Business Review.
  • Major US/EU Approvals and Submissions and Phase 2/3 Clinical Data presentations being planned or achieved for the year.
This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue